58 related articles for article (PubMed ID: 32827429)
21. Divide et Impera: Drp1-mediated Mitochondrial Fission in Glioma Malignancy.
Eugenio-Pérez D; Briones-Herrera A; Martínez-Klimova E; Pedraza-Chaverri J
Yale J Biol Med; 2019 Sep; 92(3):423-433. PubMed ID: 31543706
[TBL] [Abstract][Full Text] [Related]
22. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
[TBL] [Abstract][Full Text] [Related]
23. Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.
Khan I; Gril B; Steeg PS
Cancer Res; 2019 Sep; 79(18):4689-4702. PubMed ID: 31311812
[TBL] [Abstract][Full Text] [Related]
24. Transcription factor 7 promotes the progression of perihilar cholangiocarcinoma by inducing the transcription of c-Myc and FOS-like antigen 1.
Liu Z; Sun R; Zhang X; Qiu B; Chen T; Li Z; Xu Y; Zhang Z
EBioMedicine; 2019 Jul; 45():181-191. PubMed ID: 31248836
[TBL] [Abstract][Full Text] [Related]
25. A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.
Wong BS; Shea DJ; Mistriotis P; Tuntithavornwat S; Law RA; Bieber JM; Zheng L; Konstantopoulos K
Cancer Res; 2019 Jun; 79(11):2878-2891. PubMed ID: 30975647
[TBL] [Abstract][Full Text] [Related]
26. Dynamin impacts homology-directed repair and breast cancer response to chemotherapy.
Chernikova SB; Nguyen RB; Truong JT; Mello SS; Stafford JH; Hay MP; Olson A; Solow-Cordero DE; Wood DJ; Henry S; von Eyben R; Deng L; Gephart MH; Aroumougame A; Wiese C; Game JC; Győrffy B; Brown JM
J Clin Invest; 2018 Dec; 128(12):5307-5321. PubMed ID: 30371505
[TBL] [Abstract][Full Text] [Related]
27. Current Treatment Strategies in Metastasized Differentiated Thyroid Cancer.
Kreissl MC; Janssen MJR; Nagarajah J
J Nucl Med; 2019 Jan; 60(1):9-15. PubMed ID: 30190306
[TBL] [Abstract][Full Text] [Related]
28. HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium.
Xu YF; Liu ZL; Pan C; Yang XQ; Ning SL; Liu HD; Guo S; Yu JM; Zhang ZL
Oncogene; 2019 Feb; 38(6):868-880. PubMed ID: 30177842
[TBL] [Abstract][Full Text] [Related]
29. Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers.
Untch BR; Dos Anjos V; Garcia-Rendueles MER; Knauf JA; Krishnamoorthy GP; Saqcena M; Bhanot UK; Socci ND; Ho AL; Ghossein R; Fagin JA
Cancer Res; 2018 Aug; 78(16):4642-4657. PubMed ID: 29760048
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Clathrin-Mediated Endocytosis.
Mettlen M; Chen PH; Srinivasan S; Danuser G; Schmid SL
Annu Rev Biochem; 2018 Jun; 87():871-896. PubMed ID: 29661000
[TBL] [Abstract][Full Text] [Related]
31. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Vuong HG; Altibi AM; Duong UN; Ngo HT; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
Tumour Biol; 2017 Oct; 39(10):1010428317713913. PubMed ID: 29037127
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal regulation of signaling and endocytosis: Implications for the evolving cancer cell.
Schmid SL
J Cell Biol; 2017 Sep; 216(9):2623-2632. PubMed ID: 28674108
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis.
Vuong HG; Altibi AMA; Duong UNP; Hassell L
Clin Endocrinol (Oxf); 2017 Nov; 87(5):411-417. PubMed ID: 28666074
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma.
Vuong HG; Duong UN; Altibi AM; Ngo HT; Pham TQ; Tran HM; Gandolfi G; Hassell L
Endocr Connect; 2017 Apr; 6(3):R8-R17. PubMed ID: 28219937
[TBL] [Abstract][Full Text] [Related]
35. Crosstalk between CLCb/Dyn1-Mediated Adaptive Clathrin-Mediated Endocytosis and Epidermal Growth Factor Receptor Signaling Increases Metastasis.
Chen PH; Bendris N; Hsiao YJ; Reis CR; Mettlen M; Chen HY; Yu SL; Schmid SL
Dev Cell; 2017 Feb; 40(3):278-288.e5. PubMed ID: 28171750
[TBL] [Abstract][Full Text] [Related]
36. Dynamin2 GTPase contributes to invadopodia formation in invasive bladder cancer cells.
Zhang Y; Nolan M; Yamada H; Watanabe M; Nasu Y; Takei K; Takeda T
Biochem Biophys Res Commun; 2016 Nov; 480(3):409-414. PubMed ID: 27771248
[TBL] [Abstract][Full Text] [Related]
37. Membrane fission by dynamin: what we know and what we need to know.
Antonny B; Burd C; De Camilli P; Chen E; Daumke O; Faelber K; Ford M; Frolov VA; Frost A; Hinshaw JE; Kirchhausen T; Kozlov MM; Lenz M; Low HH; McMahon H; Merrifield C; Pollard TD; Robinson PJ; Roux A; Schmid S
EMBO J; 2016 Nov; 35(21):2270-2284. PubMed ID: 27670760
[TBL] [Abstract][Full Text] [Related]
38. Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer: Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality.
Liu R; Bishop J; Zhu G; Zhang T; Ladenson PW; Xing M
JAMA Oncol; 2017 Feb; 3(2):202-208. PubMed ID: 27581851
[TBL] [Abstract][Full Text] [Related]
39. The changing incidence of thyroid cancer.
Kitahara CM; Sosa JA
Nat Rev Endocrinol; 2016 Nov; 12(11):646-653. PubMed ID: 27418023
[TBL] [Abstract][Full Text] [Related]
40. Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer.
Liu XJ; Liu WL; Yang FM; Yang XQ; Lu XF
Onco Targets Ther; 2015; 8():2101-9. PubMed ID: 26316779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
